Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Toviaz, Fesoterodine fumarate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 6,550Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of January 14, 2026
    Enforcement Report - Week of January 14, 2026

    14 Jan 2026

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-14-2026-32682.pdf

    FDA
    14 Jan 2026
    Share Share
    Health Canada Issues Recalls of Sandoz's Fesoterodine
    Health Canada Issues Recalls of Sandoz's Fesoterodine

    21 Mar 2025

    // HEALTH CANADA

    https://recalls-rappels.canada.ca/en/alert-recall/sandoz-fesoterodine-fumarate-8-mg-tablet-out-specification-diester-impurity-0

    HEALTH CANADA
    21 Mar 2025
    Share Share
    Health Canada Issues Recall of Sandoz's Fesoterodine Fumarate
    Health Canada Issues Recall of Sandoz's Fesoterodine Fumarate

    16 May 2024

    // HEALTH CANADA

    https://recalls-rappels.canada.ca/en/alert-recall/sandoz-fesoterodine-fumarate-8-mg-tablet-out-specification-diester-impurity

    HEALTH CANADA
    16 May 2024
    Share Share
    Hetero`s Generic Fesoterodine Fumarate Receives Approval in the U.S.
    Hetero`s Generic Fesoterodine Fumarate Receives Approval in the U.S.

    09 Jan 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204792

    FDA
    09 Jan 2024
    Share Share
    Lupin's Generic Fesoterodine Fumarate Receives Approval in the U.S.
    Lupin's Generic Fesoterodine Fumarate Receives Approval in the U.S.

    05 Jan 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204983

    FDA
    05 Jan 2023
    Share Share
    Accord healthcare's Generic Fesoterodine Fumarate Receives Approval in U.S.
    Accord healthcare's Generic Fesoterodine Fumarate Receives Approval in U.S.

    04 Jan 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205012

    FDA
    04 Jan 2023
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.